IP Verse

High Dose And Low Volume Botulinum Toxin Treatment Of Facial Wrinkles

Patent No. EP4161562 (titled "High Dose And Low Volume Botulinum Toxin Treatment Of Facial Wrinkles") was filed by Merz Pharma on Jun 4, 2021. The application was issued on Nov 20, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
IPSEN BIOPHARMAAug 20, 2025MATHYS & SQUIRE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP4161562

MERZ PHARMA
Application Number
EP21728601A
Filing Date
Jun 4, 2021
Status
Granted And Under Opposition
Oct 18, 2024
Publication Date
Nov 20, 2024
External Links
Slate, Register , Google Patents